• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Study offers updated guidelines on useof breast MR imaging

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 4
Volume 31
Issue 4

Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.

Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.

Among the recommendations is that MRI is not a substitute for screening or diagnostic mammography and, when indicated, diagnostic breast ultrasound, the guidelines state. But when cancer is found in the lymph nodes but not the breast, MRI can find the location of cancer in the breast in nearly 60% of women.

The guidelines were developed by Dr. Constance Lehman, a professor of radiology at the University of Washington and director of breast imaging at Seattle Cancer Care Alliance, and colleagues. They were based on an extensive review of published, peerreviewed studies.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.